MPA, GPA, EGPA, Oh My! Vasculitis CME for the Fearless Clinician

Online, on-demand, complimentary

As a pre-symposium to the Biologic Therapies VII Summit, Primary Vasculitides: Best Practices and Future Advances, was held on April 5 in Cleveland, Ohio.

Advertising Policy

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy

Now, the entire program is available as a complimentary, online CME series. This series captures the full meeting of international experts on vasculitis, geared toward not only rheumatologists, but also nephrologists, pulmonologists, dermatologists, neurologists, allergists, immunologists and advanced practice clinicians. Advances in traditional and biologic therapies for a variety of forms of vasculitis including microscopic polyangiitis (MPA), granulomatosis with polyangiitis (GPA), eosinophilic granulmoatosis with polyangiitis (EGPA), and IL6 targeting for giant cell arteritis (GCA) are presented. Finally, a captivating clinical session on diagnostic conundrums in vasculitis that emphasizes sorting out the mimics will test your clinical acumen.

Whether you need an update on the current standard of care and management of patients with primary vasculitides or are interested in hearing from leaders in the field, be sure to check out all that this series has to offer.  

A sampling from Cleveland Clinic experts:

Advertising Policy

EGPA: Look Carefully at the Heart with W.H. Wilson Tang, MD, Director of Cleveland Clinic’s Center for Clinical Genomics and staff cardiologist in the Sydell and Arnold Miller Family Heart & Vascular Institute 

GPA and MPA: Is There Still a Role for Conventional Therapy? with Carol Langford, MD, MHS, FACP, Director of the Center for Vasculitis Care and Research 

EGPA with Rula Hajj-Ali, MD, Associate Director of the Center for Vasculitis Care and Research

Advertising Policy

CNS Vasculitis: Diagnostic Update with Leonard H. Calabrese, DO, Director of the RJ Fasenmyer Center for Clinical Immunology

These activities have been approved for AMA PRA Category 1 Credit™.